LIMULA
Limula provides a unique platform technology enabling scale out of cell therapy production. By bringing manufacturing closer to the patients, our solution will broaden access to these highly personalised treatments. Our patented solution is composed of an automation unit and single use kits, allowing healthcare providers to safely manufacture CGT in a decentralized manner. We support companies at all stages of the cell therapy life cycle, from R&D to routine production.
LIMULA
Industry:
Biotechnology Genetics Manufacturing Pharmaceutical
Founded:
2020-01-01
Address:
La Tour-de-peilz, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.limula.ch
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.95 M USD
Technology used in webpage:
Euro Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Abogen Biosciences
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.
Brenus Pharma
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Grant - Limula
Foundation for Technological Innovation (FIT)
Foundation for Technological Innovation (FIT) investment in Debt Financing - Limula
MassChallenge
MassChallenge investment in Grant - Limula
Venture Kick
Venture Kick investment in Grant - Limula
Official Site Inspections
http://www.limula.ch Semrush global rank: 8.31 M Semrush visits lastest month: 334
- Host name: 94.0.153.160.host.secureserver.net
- IP address: 160.153.0.94
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Limula"
Limula – Cell and Gene Therapy Made Easy
Our company is based in Lausanne, Switzerland. We thrive in this world-class ecosystem, tapping into the country’s long tradition of Pharma and Biotech. We have privileged access to …See details»
About – Limula
Limula offers a unique technology supporting routine manufacturing of highly-personalised cell therapies. We address one of the biggest challenges in this industry - How to enable the transition from open and manual methods …See details»
News – Limula
May 21, 2024 · Limula répond aux besoins des thérapies cellulaires 24heures - 27.05.2024 Swiss-based Limula raised over €6.2 million aiming to democratise access to life-saving cell and gene therapiesSee details»
Limula SA - Swiss Biotech
Limula is a Life Science Tools company based in Lausanne, Switzerland, offering a modular solution for on-demand and at-scale manufacturing of highly-personalised Cell & Gene Therapy products in a single device, using end-to …See details»
Meet Luc Henry, CEO and Co-founder at Limula
Oct 10, 2023 · Meet Luc Henry, CEO and Co-founder at Limula. Can you explain the inspiration behind starting Limula and how you came up with the idea for an automated solution for cell therapy manufacturing?See details»
Limula : des traitements personnalisés contre le cancer ... - Innovaud
EPFL startup Limula has set out to change all that. The firm, based at Biopôle in Lausanne, has developed a single-use plastic “kit” that hospitals can use directly on site, with each kit capable …See details»
Limula Automated Cell Therapy Manufacturing gets FIT …
Feb 16, 2022 · Founded at the end of 2020, Limula has developed a platform for the automated production of personalised therapies. The Tech Seed loan from the Foundation for Technological Innovation (FIT) will help Limula finalise its …See details»
Limula: CHF 6.2 million to further develop cell and gene therapy ...
May 21, 2024 · Life Science Tools company Limula announces today it has raised CHF6.2 million ($6.8 million) to take their solution for automating cell therapy manufacturing to the next stage …See details»
Limula and CSEM cooperation – Making personalized cancer …
Feb 3, 2023 · Limula is a Cell & Gene Therapy (CGT) company based in Lausanne, Switzerland. Its mission is to bring the most personalized cancer treatments to the patients in need, at …See details»
Making personalized cancer therapies accessible to all
CSEM has supported Lausanne-based start-up Limula in its mission to make cell therapies more affordable, and to facilitate access to these personalized treatments. The start-up's technology enables the automated production of …See details»
Limula raises $6.8M to scale cell and gene therapies
May 21, 2024 · Lausanne-based startup Limula has raised CHF 6.2M ($6.8M) to take its cell- and gene-therapy manufacturing solution to the next stage of development while continuing to …See details»
Limula raises CHF 6.2 million to develop automated cell and gene ...
May 23, 2024 · Life Science Tools company Limula announces it has raised 6.2 million Swiss francs ($6.8 million) to take their solution for automating cell therapy manufacturing to the next …See details»
Limula: CHF 2.5 million non-dilutive funding for cell and gene …
Apr 28, 2023 · Limula SA, a company based in Lausanne, Switzerland, announced that it has been awarded a CHF 2.5 million (€ 2.5 million) non-dilutive Accelerator grant from Innosuisse, …See details»
Limula secures CHF 6.2M for its automated cell therapy platform
May 21, 2024 · Limula, a Lausanne-based life science company, has raised CHF 6.2 million in an oversubscribed seed round to further develop its automated Cell and Gene Therapy (CGT) …See details»
Limula SA receives CHF 2.5 million from Innosuisse Swiss ... - BioAlps
Oct 31, 2024 · Limula SA receives CHF 2.5 million in non-dilutive funding to accelerate the industrialisation of a closed, automated, and modular solution for Cell and Gene Therapy …See details»
Limula wins highly competitive Swiss Accelerator grant to bring …
Apr 28, 2023 · Limula SA receives CHF 2.5 million in non-dilutive funding to accelerate the industrialisation of a closed, automated, and modular solution for Cell and Gene Therapy …See details»
Limula SA. (5/21/24). "Press Release: Limula Raises CHF 6.2 Million …
Life Science Tools company Limula announces today it has raised 6.2 million Swiss francs ($6.8 million) to take their solution for automating cell therapy manufacturing to the next stage of …See details»
Limula SA - top100startup.ch
Limula SA: Limula is a Life Science Tools company based in Lausanne, Switzerland, offering a modular solution for on-demand and at-scale manufacturing of highly-personalised Cell & …See details»
Limula wins Innosuisse grant to integrate non-viral gene transfer ...
Dec 1, 2022 · Swiss Start-up Limula receives over EUR 1 million of additional non-dilutive funding to expand its closed, automated and modular cell and gene therapy manufacturing platform. In …See details»
Limula secures USD 6.8 million to revolutionize Cell and Gene …
May 21, 2024 · Limula has raised USD 6.8 million to advance its automated cell therapy manufacturing solution. The seed round was led by LifeX Ventures, Verve Ventures, Zühlke …See details»